WT1 and kidney cancer: All in all, the documented immunoexpression patterns for WT1 and TDs in RCC tumor cells, TMS, and tumor-adjacent HRT generate numerous hypotheses about the origins and biology of RCCs and, potentially, may even inform kidney cancer therapeutics.